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A B S T R A C T
Background: Insight is impaired in the majority of schizophrenia patients. The exact neural correlates of im-
paired insight remain unclear. We assume that the ability to regulate emotions contributes to having good
clinical insight, as patients should be able to regulate their emotional state in such a way that they can adapt
adequately in order to cope with impaired functioning and negative stigma associated with a diagnosis of
schizophrenia. Numerous studies have shown emotional dysregulation in schizophrenia. We investigated the
association between insight and brain activation and connectivity during emotion regulation.
Methods: Brain activation during emotion regulation was measured with functional MRI in 30 individuals with
schizophrenia. Two emotion regulation strategies were examined: cognitive reappraisal and expressive sup-
pression. Clinical insight was measured with the Schedule for the Assessment of Insight – Expanded, and cog-
nitive insight was measured with the Beck Cognitive Insight Scale. Whole brain random eﬀects multiple re-
gression analyses were conducted to assess the relation between brain activation during emotion regulation and
insight. Generalized psychophysiological interaction (gPPI) was used to investigate the relation between task-
related connectivity and insight.
Results: No signiﬁcant associations were found between insight and neural correlates of cognitive reappraisal.
For clinical insight and suppression, signiﬁcant positive associations were found between symptom relabeling
and activation in the left striatum, thalamus and insula, right insula and caudate, right pre- and postcentral
gyrus, left superior occipital gyrus and cuneus and right middle and superior occipital gyrus and cuneus.
Furthermore, reduced clinical insight was associated with more connectivity between midline medial frontal
gyrus and right middle occipital gyrus. For cognitive insight and suppression, signiﬁcant positive associations
were found between self-reﬂectiveness and activation in pre- and postcentral gyrus and left middle cingulate
gyrus.
Conclusions: Our results suggest an association between the capacity to relabel symptoms and activation of brain
systems involved in cognitive-emotional control and visual processing of negative stimuli. Furthermore, poorer
self-reﬂectiveness may be associated with brain systems subserving control and execution.
1. Introduction
Clinical insight is impaired in the majority of schizophrenia patients
(Dam, 2006). It includes the following dimensions: (i) illness aware-
ness, (ii) attribution of symptoms to the illness, and (iii) awareness of
need for treatment (David, 1990). Impaired clinical insight is one of the
most common reasons for poor treatment adherence, and a strong as-
sociation between impaired clinical insight and poorer outcome of the
disorder has been shown (Lincoln et al., 2006). Clinical insight is se-
parated from cognitive insight, which relates to patients' attributive
metacognitive ability. Cognitive insight is deﬁned as the ability to
evaluate and reﬂect upon one's own aberrant views and interpretations
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(Beck et al., 2004; Cooke et al., 2010). Clinical insight requires the
ability to reﬂect upon oneself (i.e. cognitive insight), but also the
abilities to inhibit one's own perspective, to take someone else's per-
spective and to switch between perspectives until the perspective is
found that matches reality best. Consequently, it has been suggested
that social cognitive functions such as self-reﬂectiveness and perspec-
tive taking, as well as cognitive functions such as cognitive (inhibitory)
control and cognitive ﬂexibility (Pijnenborg et al., 2011) may play an
important role in clinical insight. We assume that the ability to regulate
emotions contributes to having good clinical insight, as patients should
be able to regulate their emotional state in such a way that they can
adapt adequately in order to cope with impaired functioning and ne-
gative stigma associated with a diagnosis of schizophrenia (Pijnenborg
et al., 2011). Better emotion regulation skills may also be associated
with being more open to considering the possibility of having a mental
disorder. The association between emotion regulation and insight has
not been studied before. Results of an earlier study suggested that
stigma resistance was associated with emotion regulation in patients
with schizophrenia (Raij et al., 2014). A model illustrating the re-
lationship between several processes that may be involved in impaired
insight can be seen in Fig. 1.
Numerous studies have shown emotional dysregulation in schizo-
phrenia (Henry et al., 2007; Horan et al., 2013; Morris et al., 2012;
Perry et al., 2012; Van der Meer et al., 2014). Emotion regulation refers
to an individual's ability to manage their emotional states (Gross,
1998). Several emotion regulation strategies exist and individuals diﬀer
in their use of them (Gross, 1998). In this study, we focus on the two
most-applied emotion regulation strategies, namely cognitive re-
appraisal and expressive suppression. Cognitive reappraisal is ante-
cedent-focused (i.e. focused on processes that precede an emotional
response) and expressive suppression is response-focused (i.e., focused
on response that is already under way). Several studies have shown that
schizophrenia patients use reappraisal less frequently and suppression
more frequently compared to healthy individuals (Kimhy et al., 2012;
Livingstone et al., 2009; van der Meer et al., 2009), while other studies
did not ﬁnd signiﬁcant diﬀerences (Badcock et al., 2011; Henry et al.,
2008; Perry et al., 2011).
During cognitive reappraisal, individuals control negative emotions
by changing their way of thinking. The neural correlates of cognitive
reappraisal of emotional stimuli have been investigated extensively in
healthy subjects using functional neuroimaging. These studies found
increased activation of the prefrontal cortex (PFC; including the dor-
solateral prefrontal cortex (DLPFC), ventrolateral PFC (VLPFC), the
dorsomedial PFC (DMPFC) and the posterior prefrontal cortex), inferior
parietal cortex, dorsal anterior cingulate cortex (dACC) and reduced
activation of the amygdala, ventral striatum, insula and ventromedial
PFC (VMPFC) during reappraisal (see Diekhof et al. (2011) and Buhle
et al. (2014) for meta-analyses). These studies suggest top-down control
of the prefrontal cortex on areas involved in emotion processing (e.g.
the amygdala). In schizophrenia, neuroimaging studies have reported
hypo-activation of the VLPFC compared to healthy controls (Morris
et al., 2012; Van der Meer et al., 2014). During expressive suppression,
emotion expression is inhibited. Two neuroimaging studies in healthy
participants found increased activation of the DLPFC, VLPFC, and in-
sula during suppression (Goldin et al., 2008; Ohira et al., 2006).
Findings of these studies on amygdala activation were mixed, with one
study ﬁnding increased and the other study ﬁnding decreased activa-
tion during suppression (Goldin et al., 2008; Ohira et al., 2006). No
neuroimaging studies on suppression have been conducted in schizo-
phrenia yet.
We assume that emotion regulation by means of cognitive re-
appraisal requires insight and awareness, as it entails conscious eﬀort in
order to initiate it and monitor emotions during its execution.
Therefore, we hypothesize that patients with impaired insight are less
able to regulate their negative emotions through reappraisal and will
make more use of suppression. Speciﬁcally, we expect a relationship
between reappraisal and cognitive insight since reappraisal is a pre-
dominantly cognitive process. We hypothesize that patients with poorer
cognitive insight show increased activation of prefrontal and emotional
arousal-related areas, as well as more connectivity between prefrontal
and emotional arousal-related areas suggesting increased mental eﬀort
and top-down control to exert cognitive reappraisal. In addition, we
hypothesize that patients with poorer clinical insight will make more
use of suppression and, therefore, will show less brain activation of and
connectivity between relevant areas (DLPFC, VLPF and insula) during
suppression compared to patients with better insight. A visualization of
our hypotheses can be seen in Fig. 2.
2. Methods
2.1. Participants
35 individuals with schizophrenia (SZ; 73% men) and 16 healthy
controls (HC; 67% men) were included in this study. All patients were
diagnosed with schizophrenia by a psychiatrist according to DSM-IV-TR
(American Psychiatric Association, 2000) and ICD-10 criteria (World
Health Organisation, 2012), which was conﬁrmed with the Mini In-
ternational Neuropsychiatric Interview (MINI-plus) (Sheehan et al.,
1998). Patients were recruited from several mental health institutions
in the Netherlands in a consecutive manner. All healthy controls were
assessed with the MINI-plus (Sheehan et al., 1998) to conﬁrm lack of
personal history of psychiatric, somatic and neurological illnesses. They
were matched to the patient group on age, handedness, sex and edu-
cation. All participants were of ages 18 and above and were able to give
informed consent. Exclusion criteria for this study were having an acute
psychosis, having a co-morbid psychiatric, somatic and/or neurological
disorder, drug use, change of medication within the last week, use of a
benzodiazepine equivalent to> 3mg lorazepam, electroconvulsive
therapy within the last year and MRI contra-indications (i.e. metal
implants, red ink tattoos, pregnancy or possibility thereof and claus-
trophobia). All participants provided informed consent and received 45
euros for participation. The study protocol was approved by the med-
ical ethical board of the University Medical Center Groningen and was
in accordance with the latest version of the Declaration of Helsinki.
Five patients and one healthy individual were excluded from ana-
lyses for diﬀerent reasons: lack of understanding of fMRI task (2 SZ),
MRI artefact (1 SZ), lack of logging of onset times of diﬀerent condi-
tions fMRI task (1 SZ) and excessive head motion (1 SZ and 1 HC). This
left a group of 30 SZ patients and 15 HC for analyses; their clinical and
demographic characteristics can be seen in Table 1.
Fig. 1. Model of impaired insight in schizophrenia. Adapted from Pijnenborg
et al. (2011).




Severity and frequency of last week's symptoms were assessed with
the Positive and Negative Syndrome Scale (PANSS) (Kay et al., 1987),
which is a semi-structured interview scored by a trained interviewer.
The PANSS was used for the assessment of general psychopathology as
well as positive and negative symptoms.
2.2.2. Clinical insight
Clinical insight was measured with the Schedule for the Assessment
of Insight – Expanded (SAI-E) (Kemp and David, 1997). The SAI-E is a
12-item researcher-reported semi-structured interview measuring three
subdimensions of insight: (1) awareness of illness, (2) relabeling of
symptoms and (3) awareness of need for treatment (David, 1990).
Three subscale scores can be calculated, as well as a subtotal score
(items 1–9), with higher scores indicating better clinical insight. These
subscales have been conﬁrmed with factor analysis in several studies
that found three similar factors (Dantas and Banzato, 2007; David et al.,
2003; Konstantakopoulos et al., 2013). Subscale scores as well as SAI-E
subtotal score were used for fMRI analyses.
2.2.3. Cognitive insight
Cognitive insight was measured with the Beck Cognitive Insight
Fig. 2. Visualization of hypotheses.
Table 1
Clinical and demographic characteristics of all participants.
Variable Schizophrenia patients (mean (SD)) Healthy controls (mean (SD)) Signiﬁcance
Age (years)a 35.00 (10.16) (range: 20–57) 33.60 (11.11) (range: 21–53) F(1,43)= 0.178, p=0.675
Sex (percentage male)a 73% 67% χ(1)= 0.216, p= 0.642
Level of educationa,b 5.37 (1.16) 5.60 (0.91) U=202.5, p= 0.571
Self-reported handedness (percentage right-handed)a 87% 87% χ(1)= 0, p= 1
Estimate of premorbid intelligencea,c 98.00 (16.30) 93.1 (10.05) F(1,42)= 1.508, p=0.226
Age of illness onset (years) 23.83 (7.73)
Illness duration (years)d 11.10 (8.60)











Negative symptoms 14.27 (4.61)
Positive symptoms 14.47 (5.47)
General psychopathology 29.17 (7.73)
Total 57.90 (14.71)
SAI-E
Awareness of illness 8.84 (3.49)
Relabeling of symptoms 3.57 (2.14)





Composite score 6.03 (5.01)
Abbreviations: PANSS=Positive and Negative Syndrome Scale; SAI-E= Schedule for the Assessment of Insight – Expanded; BCIS=Beck Cognitive Insight Scale.
a No signiﬁcant diﬀerences were found between groups in age (tested with ANOVA), sex (tested with Chi-Square test), level of education (tested with Mann-
Whitney U Test), handedness (tested with Chi-Square test) and estimate of premorbid intelligence (tested with ANOVA).
b According to Verhage (1964).
c Measured with the Dutch Adult Reading Test (DART). DART-scores were missing for 1 healthy control.
d Illness duration information was missing for 1 patient.
e Some patients were using multiple antipsychotic medications.
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Scale (BCIS) (Beck et al., 2004). The BCIS is a self-report 15-item
questionnaire that consists of two subscales: (1) self-reﬂection (SR; e.g.,
‘I am sometimes wrong about how people feel and think about me’; 9
items) and (2) self-certainty (SC; e.g., ‘my interpretations of my ex-
periences are absolutely right’; 6 items). These two factors have been
conﬁrmed by multiple studies (Buchy et al., 2012; Favrod et al., 2008;
Gutiérrez-Zotes et al., 2012; Kao and Liu, 2010; Uchida et al., 2009).
Two subscales scores and a composite index score (self-reﬂection score
minus self-certainty score) were computed. All three scores were used
for subsequent fMRI analyses. Poor cognitive insight is reﬂected by high
scores on self-certainty, low scores on self-reﬂection and a low com-
posite index score.
2.2.4. Emotion regulation questionnaire
Emotion regulation strategies were assessed with the Dutch version
of the Emotion Regulation Questionnaire (ERQ) (Gross and John,
2003). This is a 10-item self-report questionnaire that measures the use
of reappraisal and suppression as emotion regulation strategies in daily
life. This questionnaire consists of 6 items measuring reappraisal (e.g. ‘I
control my emotions by changing the way I think about the situation I
am in’) and 4 items measuring suppression (e.g. ‘I control my emotions
by not expressing them’). These subscales have been conﬁrmed with
factor analysis (Melka et al., 2011). All items were measured on a 7-
point scale (strongly disagree - strongly agree). Subscale scores were
calculated by dividing the total subscale score by the number of sub-
scale items.
2.2.5. Aﬀect
The Positive and Negative Aﬀect Schedule (PANAS) (Watson et al.,
1988) is a 20-item self-report measure assessing positive and negative
aﬀect at this moment. Responses were measured on a 5-point scale
(very slightly or not at all - extremely). The PANAS has been shown to
be a reliable and valid measure of aﬀective state (Crawford and Henry,
2004).
2.3. Task and stimuli
The emotion regulation task of event-related design that is used in
this study is based on the theoretical framework of Gross (Gross, 1998),
and was designed and published by Ochsner et al. (2002). The task was
programmed using E-Prime software version 1.0.2 (Psychology Soft-
ware Tools, Pittsburg, PA, USA), run in Windows, which also recorded
participants' responses. This task was validated in a previous study by
our group examining healthy individuals, patients with schizophrenia
and non-aﬀected siblings (Van der Meer et al., 2014). Before scanning,
all participants received training to make sure they completely under-
stood the task and what was asked of them. They told the researcher
how they would regulate their emotions during the diﬀerent conditions
in order to practice all diﬀerent emotion regulation strategies until
complete understanding of the task. The emotional pictures, extracted
from the International Aﬀective Picture System (IAPS), which were
used as stimuli during training, were diﬀerent from pictures used
during the experiment.
During the experiment, 88 stimuli were shown in total, of which 66
were negative (mean valence: 2.6; mean arousal: 5.7) and 22 were
neutral (mean valence: 1.3, mean arousal: 1.9). Stimuli were selected in
a randomized way. Each trial lasted 15.5 s and consisted of six parts: (1)
view (2 s), (2) regulation (4 s), (3) lingering (2 s), (4) rating (3 s), (5)
relax (4 s) and (6) intertrial interval (0.5 s) (see Fig. 3). Only the reg-
ulation part diﬀered between trials, and could be one of ﬁve conditions:
attend neutral, attend negative, reappraise, suppress and increase.
During View, participants were shown the emotional picture with the
instruction ‘view’ asking participants to look at the picture. After that,
instructions were presented on the screen below the picture instructing
the participants how to regulate their emotional reaction to the picture
(Regulation: attend, reappraise, suppress or increase). Instructions were
in accordance with (Ochsner et al., 2002) and (Goldin et al., 2008), but
translated into Dutch. During ‘attend’ the participants were asked to
just look at the picture, while the participants were asked to regulate
their emotions during ‘reappraise’, ‘suppress’ and ‘increase’. During
‘reappraisal’ the participant was instructed to reinterpret the picture in
a way that decreases negative feelings. The instructions for ‘suppres-
sion’ asked the participant to suppress the expressive emotional reac-
tion provoked by the picture. They were instructed that no one should
be able to read their emotions from their face. The ‘increase’ condition
entailed the opposite of the ‘reappraise’ condition, so participants had
to increase the negative emotions caused by the stimulus. Stimuli were
shown for 6 s in total (during View and Regulation). After the emotion
regulation part of this task, the participants were asked to let their
emotions linger while a black screen was shown to them (Lingering).
Consequently, participants had to rate how negatively they felt at that
moment (Rating; score 1–4 from ‘not negative’ to ‘very negative’). At
last, the word ‘relax’ was presented and participants could relax for 4 s
(Relax). The intertrial interval lasted 0.5 s and consisted of a black
screen to indicate start of a new trial. Each regulation condition oc-
curred 22 times; hence, the experimental paradigm consisted of 110
trials (22 trials per condition) of 15.5 s. After every tenth trial, a rest
block was included in which a ﬁxation cross was presented for 20 s
(Fixation; baseline). Total fMRI scan duration for this task was around
32min and the task was scanned in two sessions to prevent fatigue.
2.4. Image acquisition
All scans were made in the Neuroimaging Center of the University
Medical Center Groningen (UMCG) in Groningen. Scans were acquired
using a 3T Phillips Intera Quaser (Philips Intera, Best, the Netherlands)
equipped with a synergy SENSE eight-channel head coil. Functional
images were acquired using a T2*-weighted echo-planar sequence
producing 37 interleaved axial slices tilted approximately 30°, a
thickness of 3.5mm and no slice gap to cover the entire cortex
(TR=2 s; TE= 30ms; ﬂip angle= 70°; FOV=224, 129.5, 224;
64× 62 matrix of 3.5× 3.5×3.5 voxels). In addition, a T1-weighted
3D fast ﬁeld echo (FFE) anatomical image (voxel size 1×1×1mm)
containing 170 slices (TR=9ms; TE= 3.54ms; slice thick-
ness= 1mm; 256×256 matrix; FOV 232, 170, 256mm) was acquired
parallel to the bicommissural plane. Every run started with several
dummy scans to ensure steady state magnetization before acquiring the
data used for analyses.
2.5. Method of analysis
2.5.1. Demographic and clinical characteristics and insight
SPSS 20 (SPSS Inc., Chicago, IL, USA) was used for all behavioral
data analyses. Methods and results of group comparisons (SZ vs HC) as
well as correlations between insight and demographic or clinical vari-
ables are described in Supplementary Materials 1.1 and 2.1.1, respec-
tively. Haloperidol equivalents were calculated based on antipsychotic
dose (Andreasen et al., 2010). Haloperidol equivalents of pimozide
were calculated by ﬁrst converting to olanzapine according to (Gardner
et al., 2010), followed by conversion to haloperidol according to
(Andreasen et al., 2010).
2.5.2. Emotion regulation questionnaire
We calculated Pearson correlations between a priori emotion reg-
ulation strategies and insight, results of which were evaluated at an
FDR-corrected level corrected for 4 tests. Methods and results of group
comparisons are described in Supplementary Materials 1.2 and 2.1.2,
respectively.
2.5.3. Aﬀect
Pearson correlations between a priori (negative and positive) aﬀect
and insight were calculated. A threshold of p < 0.05, two-tailed, was
D.I. Larabi et al. NeuroImage: Clinical 20 (2018) 762–771
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used as the standard for statistical signiﬁcance and all correlations
between PANAS subscales and insight were evaluated at an FDR-cor-
rected level corrected for 4 tests. Methods and results of group com-
parisons are described in Supplementary Materials 1.3 and 2.1.3, re-
spectively.
2.5.4. Emotion regulation task
Pearson correlations between negative aﬀect ratings during the task
and insight were calculated. A threshold of p < 0.05, two-tailed, was
used as the standard for statistical signiﬁcance and all correlations
between negative aﬀect ratings and RTs (after reappraise and suppress)
and (clinical and cognitive) insight were evaluated at an FDR-corrected
level corrected for 8 tests. Methods and results of group comparisons
are described in Supplementary Materials 1.4 and 2.1.4, respectively.
2.5.5. fMRI analyses
We analyzed fMRI-data using Statistical Parametric Mapping
(SPM12 – version r6223) (www.ﬁl.ion.ucl.ac.uk/spm) run in Matlab
8.1 (The MathWorks Inc., Natick, MA, USA). First, all images were
checked for artefacts (1 patient was excluded, as mentioned in 2.1
Participants subsection). Functional as well as anatomical images were
reoriented parallel to the AC-PC plane. Functional images were cor-
rected for slice timing (reference slice: middle slice) and realigned to
the ﬁrst volume of the ﬁrst run. The details of the transformation were
checked and participants who showed>6mm movement across the
session were dropped from analyses (1 HC and 1 SZ, as mentioned in
2.1 Participants subsection). The mean functional scans created during
realignment were coregistered to the anatomical scans (4th degree B-
spline interpolation). Functional images were spatially normalized
based on the Montreal Neurological Image (MNI) T1 template and
smoothed with a 6mm full-width half maximum (FWHM) Gaussian
smoothing kernel. Smoothing was done with a 6mm kernel given our a
priori interest in the amygdala. Coregistration and normalization were
checked after coregistration and/or normalization and, if necessary,
adjusted manually (adjustment after coregistration, n= 31; additional
adjustment after normalization, n= 21). In case of manual adjustment
after normalization, functional images were resliced after this adjust-
ment.
At ﬁrst level, a general linear model (GLM) was created which in-
cluded 14 condition-regressors (7 condition-regressors per session)
modelled with a boxcar function convolved with a canonical hemody-
namic response function (HRF): (1) view, (2) attend neutral, (3) attend
negative, (4) reappraisal, (5) suppression, (6) increase, (7) after. The
regressor ‘after’ included the Lingering, Rating and Relax parts of the
task. Fixation crosses and intertrial intervals were seen as baseline brain
activity. The six estimated motion parameters and their derivatives
were added to the model to correct for motion eﬀects. A high-pass ﬁlter
cut-oﬀ of 128 s was used, and serial correlations were accounted for
using an autoregressive (AR (1)) model during classical (ReML) para-
meter estimation. Three contrasts were deﬁned for each participant: (1)
reappraise versus attend negative, (2) suppress versus attend negative,
and (3) increase versus attend negative. These contrasts examine which
brain regions are activated more during emotion regulation compared
to attending to a negative picture, to isolate regions that are important
for these emotion regulation strategies. The increase condition was not
of our interest, but activation during this condition and diﬀerences
between groups in activation during this condition will be described in
Supplementary Materials 2.2 and 2.3, respectively.
At second level, ﬁrst, main task eﬀects were examined in all parti-
cipants with one sample t-tests using contrasts reappraise> attend
negative, suppress> attend negative and increase> attend negative.
Second, between group diﬀerences were examined with two sample t-
tests using the same contrasts. Between group analyses were conducted
to examine whether patients engaged additional or diﬀerent neural
resources compared to HC. Third, second-level whole brain random
eﬀects multiple regression analyses were conducted to assess the rela-
tion between brain activation during emotion regulation and insight.
Only patients were included in these analyses (n=30), and whole
brain as well as region of interest (ROI) analyses were conducted.
Contrasts reappraisal> attend negative and suppression> attend ne-
gative were used for further analyses, as there was no rationale for
examining the association between insight and use of reappraisal to
increase negative emotions. Thus, the contrast reappraisal> attend
negative or suppression> attend negative was entered, with demeaned
clinical insight scores (SAI-E subtotal score) or demeaned cognitive
insight scores (BCIS composite index score) as covariate of interest. The
same analysis was done for the subscale scores, with either the three
demeaned SAI-E subscale scores as covariates of interest or the de-
meaned BCIS subscale scores as covariates of interest. All of these
analyses were thresholded with family-wise error (FWE) cluster-level
correction at p < 0.05 (using an initial threshold of p < 0.001, un-
corrected). No extra correction was applied to correct for the number of
contrasts tested. For the ROI random eﬀects multiple regression ana-
lyses, masks of the IFG were made using Marsbar (Brett et al., 2002),
based on group level activation during either reappraise> attend ne-
gative or suppress> attend negative. For reappraisal> attend nega-
tive, the mask included the right inferior frontal gyrus, insula and su-
perior temporal gyrus. Two masks were made for suppression> attend
negative; the ﬁrst mask included the left inferior frontal gyrus and in-
sula, while the second mask included the right inferior frontal gyrus and
insula. Results of these ROI random eﬀects multiple regression analyses
were viewed with voxel-level pFWE < 0.05 and small volume correc-
tion (SVC).
In order to investigate task-related connectivity, we used general-
ized psychophysiological interaction version 13.1 (gPPI) (McLaren
et al., 2012). One seed region of interest, with a 6mm-radius, was de-
ﬁned functionally per contrast based on peak activation of the group:
(1) left IFG activated during reappraisal> attend negative (MNI co-
ordinates -52 20 12) and (2) midline MFG activated during suppres-
sion> attend negative (MNI coordinates 2 2 60). The seed ROIs were
made using Marsbar (Brett et al., 2002). First, the time course re-
presenting activation in the seed region (ﬁrst eigenvariate from the
timeseries) was extracted from these seed regions for each subject, and
neural activation in these seed regions was estimated by hemodynamic
deconvolution (physiological term). The estimated neural activation in
these seed regions was multiplied with task vectors and reconvolved
Fig. 3. Overview of task.
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Fig. 4. A. Association between clinical insight (SAI-E subscale relabeling of symptoms) and brain activation during suppression.
B. Association between cognitive insight (BCIS subscale self-reﬂectiveness) and brain activation during suppression.
Table 2
Associations between insight and activation or connectivity during emotion regulation.




Suppression > attend negative and SAI-E relabeling of symptoms
Positive correlation
Caudate, putamen, thalamus, insula L 211 −26 0 10 4.61
−24 −6 16 4.14
−16 −8 22 4.04
Insula, caudate R 251 22 −16 20 4.59
36 −24 24 3.91
32 −32 20 3.87
Precentral gyrus, postcentral gyrus R 162 28 −32 68 4.12
34 −20 62 4.02
20 −24 64 3.63
Superior occipital gyrus, cuneus L 228 −14 −82 42 4.11
−22 −82 30 4.09
−28 −72 18 3.67
Middle occipital gyrus, superior occipital gyrus, cuneus R 209 28 −76 30 3.83
14 −78 28 3.74
20 −84 26 3.52
Cognitive insight
Suppression > attend negative and BCIS self-reﬂection
Positive correlation
Precentral gyrus, postcentral gyrus L 113 −34 −18 44 4.85
−46 −12 38 3.49
Middle cingulate gyrus L 121 −12 −6 40 4.38
−10 2 34 3.73
−6 −14 40 3.68
Precentral gyrus, postcentral gyrus R 224 46 −16 36 4.32
36 −18 40 4.09
48 −4 32 4.05
Connectivity
Clinical insight
Suppression > attend negative and SAI-E subtotal (seed: midline medial frontal gyrus)
Negative correlation
Middle occipital gyrus (lingual gyrus, fusiform gyrus) R 104 30 −80 0 4.16
28 −68 2 3.73
26 −86 −8 3.45
All results of regression analyses are shown with an initial threshold of p < 0.001 (uncorrected) and cluster-level FWE-corrected p < 0.05.
Abbreviations: L= left; R= right.
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with a canonical HRF (PPI term). The individual task vectors were also
convolved with a canonical HRF (psychological term). Separate task
regressors were formed for each condition, and a separate interaction
term was formed for each condition. For each seed region, a ﬁrst level
(individual) GLM analysis was performed with the PPI terms, the task
regressors (psychological term), the seed region timecourse (physiolo-
gical term) and a constant. Two contrasts were created: reappraise
versus attend negative and suppress versus attend negative. For each
seed region, random eﬀects multiple regression analyses with insight
were computed at group level. Results were thresholded at FWE-cor-




No signiﬁcant correlations were found between insight and emotion
regulation strategies, a priori aﬀect, nor aﬀect ratings and RTs during
fMRI emotion regulation task after FDR-correction.
3.2. fMRI results
3.2.1. Main task eﬀects and group diﬀerences
Results of main task eﬀects and group diﬀerence analyses are shown
in Supplementary Materials 2.2 and 2.3, respectively.
3.2.2. Activation during emotion regulation and insight
No signiﬁcant associations were found between activation during
reappraisal and (clinical or cognitive) insight.
We found a positive association between scores on SAI-E Relabeling
of symptoms subscale and activation during suppression> attend ne-
gative in left striatum, thalamus and insula, right insula and caudate,
right pre- and postcentral gyrus, left superior occipital gyrus and cu-
neus, and the right middle and superior occipital gyrus and cuneus.
These results can be seen in Fig. 4A and Table 2. ROI-analyses did not
show additional activations that survived voxel-level FWE-correction
(p < 0.05). We checked overlap between these areas and areas that
were found in main task eﬀects. We ﬁrstly made ROIs of areas that were
associated with insight in Marsbar (Brett et al., 2002). Consequently,
we checked overlap between these areas and main task activation by
entering these ROIs with main task activation t-maps in MRIcroGL
(Rorden and Brett, 2000). With FWE-correction at cluster level to cor-
rect for multiple testing, the left striatum, thalamus and insula, the right
insula and caudate, and the right precentral and postcentral gyrus re-
gions did not overlap with regions observed in the main eﬀect of sup-
pression> attend negative, suggesting that these regions may be im-
portant for insight but making it uncertain which role they play in
expressive suppression. Most of these regions were activated during
suppression when viewing results with lower statistical thresholds,
however (punc < 0.01 or < 0.05).
Whole-brain regression analyses with cognitive insight showed
signiﬁcant positive correlations between scores on SR and activation
during suppression> attend negative in bilateral pre- and postcentral
gyrus, and the left middle cingulate gyrus. These results can be seen in
Fig. 4B and Table 2. ROI-analyses did not show additional activations
that survived FWE-correction at voxel-level (p < 0.05).
3.2.3. Connectivity during emotion regulation and insight
Whole brain gPPI analyses for suppression> attend negative
showed more connectivity between midline medial frontal gyrus and
the right middle occipital gyrus (lingual gyrus and fusiform gyrus) in
patients with lower SAI-E subtotal scores. This result can be seen in
Fig. 5 and Table 2. No other associations with (clinical or cognitive)
insight survived correction for multiple testing at cluster-level
(pFWE < 0.05).
4. Discussion
The aim of this study was to examine the relationship between in-
sight and brain activation as well as connectivity during emotion reg-
ulation in schizophrenia. For reappraisal, we did not ﬁnd any sig-
niﬁcant associations between activation or connectivity and insight. A
possible explanation for this could be that this study was conducted in a
structured laboratory setting which does not resemble real life, as pa-
tients were explicitly cued and instructed to reappraise. This could re-
sult in patients being abler to regulate their emotions compared to real
life, since in more complex social settings, cognitive control and
working memory may be more challenged, especially in patients with
impaired insight. For expressive suppression, we hypothesized that
patients with poorer clinical insight would show less brain activation of
relevant areas (i.e. DLPFC, VLPC and insula) during expressive sup-
pression. We indeed found that patients with poorer ability to relabel
symptoms showed less brain activation in the left striatum, thalamus
and insula and the right insula and caudate during expressive sup-
pression. In addition, they showed less brain activation in areas in-
volved in visual processing of negative stimuli (i.e. left superior occi-
pital gyrus and cuneus and right middle and superior occipital gyrus
Fig. 5. Association between clinical insight (SAI-E subtotal scores) and brain connectivity during suppression. Left: seed region in the midline medial frontal gyrus.
Right: association between clinical insight (SAI-E subtotal scores) and connectivity with seed region during suppression.
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and cuneus). The latter is strengthened by the ﬁnding that connectivity
between the midline medial frontal gyrus, an important area for ex-
ecution of emotion regulation (Kohn et al., 2014; Vanderhasselt et al.,
2013), and the right middle occipital gyrus, showed to be increased in
patients with poorer clinical insight. Our results suggest that patients
with poorer ability to relabel symptoms engage diﬀerent neural path-
ways during expressive suppression, which are implicated in cognitive-
emotional control and visual processing of negative stimuli, implying a
role of emotion regulation in clinical insight. Decreased activation of
the insula during suppression might imply decreased self-focus, as in-
dividuals with poorer ability to relabel symptoms might direct their
attention less inward to monitor their expressions (Hayes et al., 2010;
Richards and Gross, 2000). In addition, less activation of areas involved
in visual processing of negative stimuli could indicate that patients with
poorer ability to relabel symptoms implicitly reduce processing of
emotion-evoking aspects of negative stimuli during expressive sup-
pression. Other studies showed attentional shifts and reduced viewing
of negative stimuli during emotion regulation (Dillon et al., 2007;
Gross, 1998), even without instruction to do so (Bebko et al., 2011;
Hayes et al., 2010; van Reekum et al., 2007). Reduction of negative
aﬀect by use of expressive suppression appeared to be as successful in
patients with poorer insight, as we did not ﬁnd a signiﬁcant correlation
between (clinical or cognitive) insight and negative aﬀect rating after
suppression.
Other studies also found associations between clinical insight and
brain activation of areas that were shown to be involved in expressive
suppression in our study. Sapara and colleagues, for example, found
that patients with poorer insight (based on Birchwood Insight Scale
scores) showed less activation in the left putamen, extending to the
caudate, insula and IFG, compared to patients with preserved insight
during a self-monitoring task (Sapara et al., 2015). They noted that
these areas are known to be involved in self-monitoring, speciﬁcally in
the appraisal and attribution of self-generated stimuli (Kumari et al.,
2010; McGuire et al., 1996; Shergill et al., 2001). In addition, an earlier
study of our group found an association between poorer clinical insight
(lower SAI-E subtotal scores) and less activation in the left anterior
insula, among other areas, during a self-reﬂection task (van der Meer
et al., 2013). Less insula activation was interpreted as weaker emotional
and interoceptive response (Modinos et al., 2011). It was suggested that
insula activation may result from an emotional response evoked by self-
reﬂection (Fossati et al., 2003), which may fail to occur in patients with
impaired insight in whom these self-reﬂective processes are hampered
to begin with. Other studies have also suggested that the representation
of interoceptive information mediated by the insula plays an important
role in higher order processes such as self-awareness and insight
(Palaniyappan et al., 2011). Lastly, Shad and colleagues found a cor-
relation between unawareness of symptoms (as measured with the Scale
to Assess Unawareness of Mental Disorder) and activation in the left
frontal inferior operculum (including parts of the insula, caudate and
putamen) and left lingual gyrus, as well as between misattribution of
symptoms (SUMD) and activation of the left frontal inferior triangle
(including parts of the insula), right putamen and left lingual gyrus
during a self-awareness task (Shad and Keshavan, 2015). They noted
that several studies have shown involvement of the basal ganglia in
integrative and cognitive processes inﬂuencing not only sensory-motor
control, but also diﬀerent types of cognitive and limbic aﬀective func-
tions (Middleton and Strick, 2000), which underlie complex and in-
tegrative processes such as self-awareness, introspective perspective of
one's own self and consciousness (Kircher and Leube, 2003). However,
it is diﬃcult to disentangle the neural substrate of impaired insight, as
underlying (social) cognitive and emotional processes (and their neural
substrates) are related, in addition to schizophrenia being a hetero-
geneous disorder.
With regard to cognitive insight, we found that patients with poorer
self-reﬂectiveness abilities had lower activation of brain systems sub-
serving control and execution of emotion regulation (i.e. left and right
pre- and postcentral gyrus and the left middle cingulate gyrus) during
suppression. Few fMRI studies have studied the association between
brain activation during a task and cognitive insight, and associations
between higher self-reﬂection abilities or higher cognitive insight
(composite index scores) and higher activation of prefrontal areas
(VMPFC, VLPFC, DLPFC) has been found most frequently (Buchy et al.,
2015; Ćurčić-Blake et al., 2015; Lee et al., 2015; van der Meer et al.,
2013). No associations between cognitive insight and activation in the
pre- and postcentral gyrus and middle cingulate gyrus have been found
before. The midcingulate cortex (MCC) has been suggested to be in-
volved in cognitive control and intentional motor control and selection
(Hoﬀstaedter et al., 2014), while the pre- and postcentral gyri have
been associated with movement but also with motor imagery and task
execution (Stippich et al., 2002). Kohn et al. (2014) also showed
coactivation of the MCC with several emotion regulation areas such as
the insula, VLPFC, SMA and thalamus suggesting a role of this area in
emotion regulation (Kohn et al., 2014). Our results could suggest less
control and execution of suppression in patients with poorer self-re-
ﬂectiveness. These results are in line with our suggestion that patients
with poorer insight may implicitly reduce processing of emotion-
evoking aspects of negative stimuli during expressive suppression and
are therefore less involved in expressive suppression. Following this line
of thought – the avoidance of emotion-evoking aspects of negative
stimuli – is in line with the psychological denial model, which is one of
several models attempting to explain the etiology of insight. The psy-
chological denial model suggests that poor insight is caused by the use
of denial as a coping strategy in order to reduce distress caused by
stigma associated with diagnosis of schizophrenia (Cooke et al., 2005).
Patients who use denial as a coping strategy, therefore, may have im-
paired insight but suﬀer less distress as has been shown in several cross-
sectional studies (Mintz et al., 2003). We did not directly test whether
poor insight is related to the use of denial as a coping strategy, however.
No signiﬁcant relationship was found between self-reﬂectiveness abil-
ities and negative aﬀect after suppression, suggesting that patients with
poorer self-reﬂectiveness abilities were as successful in reducing nega-
tive aﬀect. No signiﬁcant relationships were found between the other
SAI-subscale scores and activation or connectivity during emotion
regulation. This is in line with the idea that insight is a multi-
dimensional construct, in which diﬀerent brain areas are involved in
separate dimensions of insight (Antonius et al., 2011; Shad et al., 2006).
In addition, no signiﬁcant relationships were found between activation
or connectivity and the BCIS self-certainty score. Other studies in-
vestigating the association between insight and activation during tasks
also found mixed results with regard to the BCIS composite index score
and subscale scores. One study found signiﬁcant associations with SR
only (van der Meer et al., 2013), while another study found signiﬁcant
associations with both the composite index score as well as SR (Lee
et al., 2015). No fMRI-studies found signiﬁcant associations with the
SC-subscale thus far.
We did not ﬁnd signiﬁcant correlations between insight and other
variables such as demographic or clinical characteristics, self-reported
use of suppression and reappraisal, and self-reported negative aﬀect
after correction for multiple testing. The lack of signiﬁcant correlations
between self-reported use of emotion regulation strategy and insight
could be explained by our measure of emotion regulation strategy (i.e.
ERQ), which is a relatively simple self-report questionnaire. This mea-
sure may not be the most optimal way to measure emotion regulation
strategies in patients with poor insight, also given that emotion reg-
ulation often occurs implicitly.
4.1. Limitations
First, this study was cross-sectional so no conclusions about the
direction of causality can be drawn. Second, antipsychotic medication
may have inﬂuenced brain activation. However, several studies have
shown that there is no common eﬀect of antipsychotics on BOLD-signal
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(Roder et al., 2013). Also, a high percentage of patients with schizo-
phrenia used antipsychotic medication in this study, which makes this
group of participants a good representation of the whole patient po-
pulation. Third, the ability to regulate emotions was diﬃcult to
monitor. The eﬀectiveness of reduction of negative aﬀect was measured
with self-reported aﬀect and neural indices in this study. Future studies
should verify eﬀectiveness of emotion regulation by measuring facial
expression and/or physiological measures of emotional reactivity such
as heart rate, skin conductance, pupil dilation and startle eye blink
magnitude. Fourth, in this study, a late-cueing design was used in which
the regulation instruction was presented 2 s after stimulus presentation.
Therefore, we did not ﬁnd activation in the amygdala during regulation
as this happened before. A design in which there is simultaneous pre-
sentation of the stimulus and instructions for regulation could be more
sensitive to amygdala activation. On the other hand, our late-cueing
design is more similar to real life in which a negative stimulus presents
before an individual starts regulating their emotions.
4.2. Conclusions
To summarize, our results suggest that patients with poorer ability
to relabel symptoms engage diﬀerent neural pathways during ex-
pressive suppression, which are implicated in cognitive-emotional
control and visual processing of negative stimuli. This may be explained
by implicit reduction of processing of emotion-evoking aspects of ne-
gative stimuli during expressive suppression. In addition, our results
suggest that patients with poorer self-reﬂectiveness abilities engage less
in control and execution of the task during suppression. Our results are
in line with the denial model that suggests that poor insight is caused by
the use of denial as a coping strategy in order to reduce distress caused
by stigma associated with diagnosis of schizophrenia. Future studies
could investigate whether incorporating emotion regulation aspects
into interventions that try to improve insight helps in improving insight
as well as prognosis, as there is still a great need for improvement
(Pijnenborg et al., 2013).
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